| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TBX3 mRNA | affects expression | 21346803
|
| C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of TBX3 mRNA | decreases expression | 18648102
|
| C016601 |
4-hydroxytamoxifen |
PD 173074 inhibits the reaction [4-hydroxytamoxifen results in increased expression of TBX3 protein] | decreases reaction|increases expression | 21098263
|
| C006780 |
bisphenol A |
bisphenol A results in increased expression of TBX3 mRNA | increases expression | 20678512
|
| C014347 |
decitabine |
decitabine results in increased expression of TBX3 mRNA | increases expression | 16367923
|
| D004967 |
Estrogens |
Estrogens affects the localization of TBX3 protein | affects localization | 21098263
|
| D004967 |
Estrogens |
Estrogens results in increased expression of TBX3 protein | increases expression | 21098263
|
| D004967 |
Estrogens |
FGF9 protein promotes the reaction [Estrogens results in increased expression of TBX3 protein] | increases expression|increases reaction | 21098263
|
| D004967 |
Estrogens |
PD 173074 inhibits the reaction [Estrogens results in increased expression of TBX3 protein] | decreases reaction|increases expression | 21098263
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of TBX3 mRNA | decreases expression | 17557909
|
| C058815 |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide |
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide results in decreased expression of TBX3 mRNA | decreases expression | 15255957
|
| C115711 |
PD 173074 |
PD 173074 inhibits the reaction [4-hydroxytamoxifen results in increased expression of TBX3 protein] | decreases reaction|increases expression | 21098263
|
| C115711 |
PD 173074 |
PD 173074 inhibits the reaction [Estrogens results in increased expression of TBX3 protein] | decreases reaction|increases expression | 21098263
|
| D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TBX3 mRNA] | affects reaction|increases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of TBX3 mRNA | decreases expression | 19482888
|
| C105686 |
SU 5402 |
SU 5402 results in decreased expression of TBX3 mRNA | decreases expression | 15255957
|
| D013467 |
Sulindac |
Sulindac results in increased expression of TBX3 mRNA | increases expression | 11906190
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TBX3 mRNA | increases expression | 20106945 16697128
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of TBX3 mRNA | increases expression | 16604517
|
| D019287 |
Zinc Sulfate |
Zinc Sulfate results in decreased expression of TBX3 mRNA | decreases expression | 16330358
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
5.56 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.46 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.46 | 15322242 11752688 14514962 |
| MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
4.96 | 7265320 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
| MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
4.34 | 7897758 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.61 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
4.61 | 11910360 |
| MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.06 | 3712494 |
| MESH:D000236 |
Adenoma |
|
Sulindac |
7.06 | 10223192 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
10.25 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.25 | 16835633 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.62 | 15623613 11535846 16460482 19003578 11874996 17611924 12394442 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.64 | 15955085 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
| MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
5.07 | 7265320 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.26 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.26 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.35 | 16456186 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
| MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.03 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.03 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
| MESH:D001913 |
Bowen's Disease |
|
Sulindac |
5.42 | 11207687 |
| MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 21098263 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.36 | 17123778 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.36 | 18320071 19208741 |
| MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
2.36 | 16642371 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.36 | 16443354 16166294 16873071 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.95 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.95 | 7296757 3581430 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
8.95 | 15341023 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.95 | 20935162 20007298 6705139 17173139 1701930 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.95 | 1917145 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.79 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.79 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 18850075 16120746 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.11 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.78 | 7505956 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.29 | 4080065 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.64 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.93 | 9022650 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.93 | 17110522 17681005 17333356 16105132 15861022 16919318 11677210 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.80 | 15668235 15340226 12621046 8697196 16354765 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.80 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.75 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.14 | 17616700 |
| MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
4.14 | 12458338 12902858 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.89 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
2.89 | 11076880 10666051 11197048 18059344 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 20055451 15322242 10048152 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.45 | 10589399 9142499 16925845 9211117 17551590 9224671 14991402 9125849 9664655 8800419 |
| MESH:D016638 |
Critical Illness |
|
Estrogens |
5.99 | 16670151 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.06 | 18551238 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 12868966 8970840 14531868 18759878 2524372 11298694 11906362 8156756 |
| MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
5.21 | 17621415 12861449 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.21 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.21 | 18289764 7440962 11289319 8291058 9022650 9653073 6482804 6679447 18692083 18648102 1440618 9328219 16192314 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.21 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.04 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.16 | 18230668 15322242 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.16 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.22 | 12538720 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.18 | 19294695 |
| MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
7.89 | 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.89 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Sulindac |
9.28 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.28 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.15 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.93 | 11558140 3922381 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.90 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.57 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.29 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.07 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.80 | 3581430 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.80 | 12235107 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.90 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.90 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.84 | 15345470 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
| MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
5.53 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
5.18 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.76 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.76 | 17994277 |
| MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
5.05 | 11910360 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.02 | 17312396 |
| MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.89 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.89 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.58 | 9664655 14991402 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
5.04 | 17063115 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.58 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.58 | 12621046 15340226 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16959395 8697196 16354765 18606429 15340226 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.23 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
| MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.91 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
| MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
4.50 | 7265320 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
6.78 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.78 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Sulindac |
5.28 | 3291741 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.28 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.31 | 16393666 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
| MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.66 | 12351151 12628509 12584176 10223192 12663524 10213222 |
| MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
5.02 | 11245490 12394442 |
| MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 9022650 8074119 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.03 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.03 | 15992940 17551590 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.43 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.43 | 6582329 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
4.28 | 15237267 |
| MESH:D007938 |
Leukemia |
|
decitabine |
6.47 | 18980019 19235587 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
6.47 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.66 | 19117987 18454857 17236224 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.66 | 19285840 16482212 16932348 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.99 | 18704418 19010910 17679729 18460780 18206229 19387464 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.99 | 19850784 17596541 16294345 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.52 | 18055864 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.17 | 16331271 17649720 9834237 16788101 17368321 17294898 17217047 17506722 15748426 16891316 16140955 16935935 16766008 16823087 19035177 19642359 19225113 19029980 19075265 17361223 17301526 17107899 17339181 17712046 12679006 |
| MESH:D017880 |
Limb Deformities, Congenital |
marker/mechanism |
|
| 9207801 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.91 | 21047994 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
8.56 | 9327722 15034207 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
8.56 | 12468960 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.31 | 16248980 18397230 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.47 | 19363144 |
| MESH:D008107 |
Liver Diseases |
|
Sulindac |
4.47 | 16867024 14986274 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
4.46 | 19073162 19812893 15975961 21047994 8742319 19482888 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.46 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.89 | 3712494 598648 6587162 1399818 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.89 | 6150874 1399818 2563599 17172636 18308698 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.89 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
2.60 | 19359593 15713900 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.60 | 19555203 11884234 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.44 | 19470736 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
| MESH:D008545 |
Melanoma |
|
decitabine |
5.28 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
Sulindac |
5.28 | 16642371 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
5.28 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.36 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.53 | 18608210 16882708 19010910 19157545 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.53 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.53 | 17484760 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.91 | 18551238 |
| MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.48 | 3581430 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.23 | 19116145 19470736 17925555 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.23 | 16594593 16946489 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
16.60 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.60 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.60 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.29 | 6679447 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.29 | 9142499 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
4.29 | 17266991 16850258 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.97 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.97 | 4026338 6482804 |
| MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.41 | 17016548 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
4.99 | 19259094 19331143 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.99 | 16936753 |
| MESH:D010146 |
Pain |
|
Sulindac |
7.18 | 3291741 |
| MESH:D010146 |
Pain |
|
Tretinoin |
7.18 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
12.47 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
12.47 | 16965848 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
12.47 | 11504793 16820089 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.47 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
| MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.65 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.68 | 10548101 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.68 | 11118676 11399792 11222880 11896295 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.77 | 17616702 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.24 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.40 | 16740699 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.56 | 12752131 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.06 | 19155313 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.06 | 16116481 16283617 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.99 | 18551238 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
5.99 | 11442880 4039156 3137016 16876388 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.87 | 6407741 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.60 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.60 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.55 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.55 | 17261132 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16045194 16684133 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.30 | 1399818 7505956 6587162 6582329 3712494 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
17.30 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
17.30 | 1399818 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
17.30 | 16026305 17045167 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.81 | 16051514 |
| MESH:D014071 |
Tooth Abnormalities |
marker/mechanism |
|
| 9207801 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
| MESH:C536937 |
Ulnar-mammary syndrome |
marker/mechanism |
|
| 9207801 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.40 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.40 | 8074119 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.40 | 17616700 19087683 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.37 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.70 | 16129372 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.79 | 14692618 |
| MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
9.79 | 18645019 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.04 | 17785578 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.04 | 16752155 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 15869587 14671159 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |
| MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.76 | 11172683 |